Patients who will receive hematopoietic stem cell transplantation
Conditions
Interventions
Flash Sensor-based monitoring for 28days
Sponsors
MINAMI Hironobu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients who are at least 20 and under 70 years of age (2)Patients who will undergo allogeneic hematopoietic stem cell transplantation (3)Patients who sign a written informed consent (4)Patients who have never used FreeStyle LibrePro
Exclusion criteria
Exclusion criteria: (1)Patients who will undergo HLA haplo-identical stem cell transplantation (2)Patients who need to perform X-ray or CT scan more than once a week (3)Patients who have infection on their upper arms for sensor sites (4)Patients who contact dermatitis (5)Patients who cannot use alcohol and chlorhexidine gluconate for sterilization (6)Patients who have implanted medical devices (7)Patients judged inappropriate perticipants for this study by their attending doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Severe bleeding of the sensor site (2)Requirement of antibiotics due to the infection of the sensor site | — |
Secondary
| Measure | Time frame |
|---|---|
| (1)Correlation with the value of blood glucose and interstitial fluid glucose (2)The times of the sensor exchanges (3)Insertion site symptoms (4)Relationship between bleeding (onset and degree) and patients characteristics | — |
Contacts
Public ContactKimikazu YAKUSHIJIN
Kobe University Hospital
Outcome results
None listed